Concepedia

A good manufacturing practice method to ex vivo expand natural killer cells for clinical use.

G Torelli, Carmela Rozera, Laura Santodonato, Nadia Peragine, Giuseppina D’Agostino, Enrica Montefiore, Mariarosaria Napolitano, Domenica M. Monque, Davide Carlei, Paola Mariglia,

PubMed · 2015 · 35 citations · 18 references

DOIFull text

Open access

Abstract

These data provide the basis for developing new NK-cell-based immunotherapeutic strategies for the treatment of patients with cancer.

References

18

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer

Jeffrey S. Miller, Yvette Soignier, Angela Panoskaltsis‐Mortari et al. · Blood · 2005 · 1.9K citations · Full text

Biology and clinical relevance of human natural killer cells

MJ Robertson, Jerome Ritz · Blood · 1990 · 919 citations · Full text

, , +4

NKAML: A Pilot Study to Determine the Safety and Feasibility of Haploidentical Natural Killer Cell Transplantation in Childhood Acute Myeloid Leukemia

Jeffrey E. Rubnitz, Hiroto Inaba, Raul C. Ribeiro et al. · Journal of Clinical Oncology · 2010 · 638 citations · Full text

, , +15

DNAM-1, A Novel Adhesion Molecule Involved in the Cytolytic Function of T Lymphocytes

Akira Shibuya, David G. Campbell, Charles Hannum et al. · Immunity · 1996 · 613 citations · Full text

, , +12

Expansion of Highly Cytotoxic Human Natural Killer Cells for Cancer Cell Therapy

Hiroyuki Fujisaki, Harumi Kakuda, Noriko Shimasaki et al. · Cancer Research · 2009 · 579 citations · Full text

, , +15